Asset
Samidorphan
Revenue
No revenue reported in loaded filings.
Clinical trials (3)
| NCT ID | Phase | Status | Start | Completion | Sponsor name | Title |
|---|---|---|---|---|---|---|
| NCT00800319 | phase1 | completed | 2008-12-01 | 2009-02-01 | Alkermes, Inc. | ALK33-001: A Study of RDC-0313 Administered to Healthy Adults |
| NCT01098435 | phase2 | completed | 2010-05-01 | 2011-05-01 | Alkermes, Inc. | ALK33-101: A Study of RDC-0313 (ALKS 33) in Adults With Binge Eating Disorder |
| NCT01366001 | phase1 | completed | 2011-08-01 | 2012-02-01 | Alkermes, Inc. | ALK33BUP-101: Safety and Pharmacodynamic Effects of ALKS 33-BUP Administered Alone and When Co-administered With Cocaine |
FDA applications (0)
This company has no applications containing this asset.